Department of Medicine, Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois, USA.
Department of Surgery, University of Chicago, Pritzker School of Medicine , Chicago, Illinois, USA.
J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S264-S269. doi: 10.1093/infdis/jiaa682.
Sepsis has been characterized as a dysregulated host response to infection, and the role of the microbiome as a key influencer of this response is emerging. Disruption of the microbiome while treating sepsis with antibiotics can itself result in immune dysregulation. Alterations in the gut microbiome resulting from sepsis and its treatment have been implicated in organ dysfunction typical of sepsis across multiple tissues including the lung, kidney, and brain. Multiple microbiota-directed interventions are currently under investigation in the setting of sepsis, including fecal transplant, the administration of dietary fiber, and the use of antibiotic scavengers that attenuate the effects of antibiotics on the gut microbiota while allowing them to concentrate at the primary sites of infection. The emerging evidence shows that the gut microbiome interacts with various elements of the septic response, and provides yet another reason to consider the judicious use of antibiotics via antibiotic stewardship programs.
败血症已被定义为宿主对感染的失调反应,而微生物组作为影响这种反应的关键因素正在逐渐显现。在使用抗生素治疗败血症时,微生物组的破坏本身可能导致免疫失调。败血症及其治疗引起的肠道微生物组的改变与包括肺、肾和脑在内的多个组织中败血症的典型器官功能障碍有关。目前正在对败血症治疗中的多种微生物组导向干预措施进行研究,包括粪便移植、膳食纤维的应用以及使用抗生素清除剂,这些干预措施可以减轻抗生素对肠道微生物组的影响,同时允许抗生素集中在感染的主要部位。新出现的证据表明,肠道微生物组与败血症反应的各个方面相互作用,这为通过抗生素管理计划谨慎使用抗生素提供了另一个理由。